8-K: System1 Faces NYSE Delisting Threat Over Financial Weakness

System1, Inc. received a notice from the NYSE for non-compliance with listing standards due to its market capitalization and stockholders' equity falling below required thresholds.

Summary

• System1, Inc. received a notice from the New York Stock Exchange (NYSE) on December 8, 2025, indicating non-compliance with Section 802.01B of the NYSE Listed Company Manual.
• The non-compliance stems from the company's 30 trading-day average market capitalization being less than $50 million as of December 5, 2025.
• Additionally, the company's last reported stockholders' equity as of September 30, 2025, was less than $50 million.
• System1 has an 18-month period to cure these deficiencies, subject to NYSE approval of a business plan.
• The company plans to notify the NYSE by December 22, 2025, of its intent to submit a business plan by January 22, 2026.
• System1 intends to explore all available alternatives to regain compliance with NYSE listing standards.

Sentiment

Score: 2

Explanation: The filing indicates severe financial distress and a significant risk of delisting from the NYSE, which is a highly negative event for a public company and its shareholders. While the company states an intent to cure, the underlying financial weakness is a major concern.

Negatives

• The company is not in compliance with NYSE continued listing standards due to its market capitalization and stockholders' equity falling below the $50 million threshold.
• Failure to cure these deficiencies within the 18-month period could lead to delisting from the NYSE.

Risks

• Potential delisting from the New York Stock Exchange if the company fails to regain compliance with market capitalization and/or stockholders' equity requirements within the 18-month cure period.
• Inability to develop and execute a business plan acceptable to the NYSE to demonstrate its ability to regain compliance.
• Negative impact on investor confidence and stock liquidity due to the non-compliance notice and potential delisting.

Future Outlook

System1 intends to submit a business plan to the NYSE by January 22, 2026, and will consider all available alternatives to cure the identified listing compliance deficiencies within the 18-month cure period.

Management Comments

• The company will notify the NYSE by December 22, 2025, of its intent to submit a business plan by January 22, 2026, to cure the market capitalization and/or stockholders' equity deficiencies.
• The company intends to consider all available alternatives to cure the listing compliance deficiencies identified by the NYSE.

Industry Context

A notice of non-compliance with major exchange listing standards, particularly due to low market capitalization and stockholders' equity, typically signals significant financial distress for a publicly traded company. This can lead to reduced investor confidence, increased volatility, and potential exclusion from institutional investment portfolios, impacting the company's ability to raise capital or maintain its public profile compared to industry peers.

Comparison to Industry Standards

• The NYSE's minimum market capitalization and stockholders' equity requirements are standard benchmarks for maintaining listing status on a major exchange. Falling below these thresholds indicates that System1 is underperforming relative to the financial health expected of a NYSE-listed company.
• Companies in the ad-tech and marketing platform sector, such as The Trade Desk or Magnite, typically maintain significantly higher market capitalizations and robust balance sheets, making System1's current financial position a notable outlier and a cause for concern regarding its competitive standing and operational stability.

Stakeholder Impact

• Shareholders face increased risk of delisting, which could severely impact stock liquidity and valuation.
• Employees may face uncertainty regarding the company's future and potential restructuring efforts.
• Advertising partners and customers may perceive increased risk, potentially affecting business relationships.

Next Steps

• Notify the NYSE by December 22, 2025, of the intent to submit a business plan.
• Submit a business plan to the NYSE by January 22, 2026, detailing how the company will regain compliance.
• Consider all available alternatives to cure the market capitalization and/or stockholders' equity deficiencies.
• Work to regain compliance with NYSE listing standards within the 18-month cure period.

Key Dates

Recommendation

The company is facing a significant risk of delisting from the NYSE due to its market capitalization and stockholders' equity falling below required thresholds. This indicates severe financial weakness and poses a substantial threat to shareholder value, liquidity, and the company's ability to operate as a publicly traded entity. While the company has an 18-month cure period, the underlying issues are fundamental and regaining compliance is not guaranteed. Investors should consider exiting their positions to mitigate further losses.

Keywords

System1, NYSE, delisting, non-compliance, market capitalization, stockholders equity, listing standards, SST